Check out our community guidelines at https://e.lilly/cg. See Full Prescribing Information including Boxed Warning at https://e.lilly/kisunlaPI and Medication Guide at https://e.lilly/kisunlaMG. To report an adverse event, product complaint, or ask an in-depth medical question, please call our help center at 1-800-LillyRx (1-800-545-5979). KisunlaTM is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. ?Lilly USA, LLC 2024.
Kisunla? (donanemab-azbt) HCP
制药业
For US Healthcare Providers. To see Prescribing Info with Boxed Warning click the Visit Website button.
关于我们
Welcome! For Prescribing Information including Boxed Warning click the “Visit Website” button. This account is intended for US Healthcare Providers Only. Check out our community guidelines at https://e.lilly/cg. See Prescribing Information https://e.lilly/kisunlaPI and Medication Guide at https://e.lilly/kisunlaMG. To report an adverse event, product complaint, or ask an in-depth medical question, please call our help center at 1-800-LillyRx (1-800-545-5979). Kisunla? is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. ?Lilly USA, LLC 2024. Please view our privacy statement here: https://privacynotice.lilly.com/
- 网站
-
https://www.kisunla.lilly.com/hcp
Kisunla? (donanemab-azbt) HCP的外部链接
- 所属行业
- 制药业
- 规模
- 1 人
- 类型
- 上市公司